Financial reports
NT 10-Q
Notice of late quarterly filing
15 Nov 16
NT 10-Q
Notice of late quarterly filing
15 Aug 16
NT 10-Q
Notice of late quarterly filing
16 May 16
NT 10-Q
Notice of late quarterly filing
16 Nov 15
NT 10-Q
Notice of late quarterly filing
14 Aug 15
NT 10-Q
Notice of late quarterly filing
18 May 15
NT 10-K
Notice of late annual filing
1 Apr 15
10-Q
2014 Q3
Quarterly report
14 Nov 14
10-Q
2014 Q2
Quarterly report
14 Aug 14
10-Q
2014 Q1
Quarterly report
15 May 14
Current reports
8-K/A
Changes in Registrant's Certifying Accountant
28 Apr 16
8-K
Changes in Registrant's Certifying Accountant
6 Apr 16
8-K
Skystar Bio-pharmaceutical Company Announces Delisting from Nasdaq
18 Dec 15
8-K
Skystar Bio-pharmaceutical Company Announces Receipt of Nasdaq Notification Letter
20 Nov 15
8-K
Skystar Bio-pharmaceutical Company Announces Receipt of Nasdaq Notification Letter
23 Oct 15
8-K
Skystar Bio-pharmaceutical Company Announces Receipt of Nasdaq Non-compliance Letter Due to Delay In Filing Form 10-Q
25 Aug 15
8-K
Skystar Bio-pharmaceutical Company Announces Receipt of Nasdaq Non-compliance Letter Due to Delay In Filing Form 10-Q
22 May 15
8-K
Skystar Bio-pharmaceutical Company Announces Receipt of Nasdaq Non-compliance Letter Due to Delay In Filing Form 10-K
15 Apr 15
8-K
Submission of Matters to a Vote of Security Holders
5 Dec 14
8-K
Material Modifications to Rights of Security Holders
21 Jul 14
Registration and prospectus
25-NSE
Exchange delisting
23 Feb 16
424B5
Prospectus supplement for primary offering
16 Jul 14
S-3/A
Shelf registration (amended)
16 Dec 13
S-3
Shelf registration
4 Dec 13
S-8
Registration of securities for employees
27 Apr 12
RW
Registration withdrawal request
25 Jun 10
S-1
IPO registration
1 Jun 10
424B1
Prospectus with pricing info
2 Jul 09
S-1/A
IPO registration (amended)
26 Jun 09
8-A12B
Registration of securities on exchange
25 Jun 09
Proxies
DEF 14A
Definitive proxy
14 Nov 14
DEF 14A
Definitive proxy
27 Sep 13
DEF 14A
Definitive proxy
21 Sep 12
DEF 14A
Definitive proxy
3 Apr 12
DEF 14A
Definitive proxy
3 Dec 10
DEF 14A
Definitive proxy
11 Dec 09
DEF 14A
Definitive proxy
13 Jun 08
PRE 14A
Preliminary proxy
23 May 08
DEF 14C
Information statement
23 Jan 06
SC 14F1
Statement regarding change in majority of directors
23 Jan 06
Other
REVOKED
Registration or securities revoked
9 Apr 19
EFFECT
Notice of effectiveness
18 Dec 13
UPLOAD
Letter from SEC
13 Sep 10
CORRESP
Correspondence with SEC
18 Aug 10
CORRESP
Correspondence with SEC
22 Jul 10
UPLOAD
Letter from SEC
9 Jul 10
EFFECT
Notice of effectiveness
30 Jun 09
UPLOAD
Letter from SEC
29 Jun 09
CORRESP
Correspondence with SEC
26 Jun 09
CORRESP
Correspondence with SEC
3 Jun 09
Ownership
SC 13G/A
Skystar Bio-pharmaceutical Co
11 Jan 16
SC 13D/A
Skystar Bio-pharmaceutical Co
2 Jun 15
4
JOHN M GREGORY
28 May 15
4
JOHN M GREGORY
7 May 15
4
JOHN M GREGORY
20 Apr 15
SC 13D/A
Skystar Bio-pharmaceutical Co
4 Feb 15
SC 13G/A
Skystar Bio-pharmaceutical Co
12 Jan 15
SC 13D/A
Skystar Bio-pharmaceutical Co
15 Dec 14
SC 13G
Skystar Bio-pharmaceutical Co
17 Jul 14
SC 13D/A
Skystar Bio-pharmaceutical Co
28 May 14